
Cumberland Pharmaceuticals Inc
CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31
Reports and events: 327 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2011-01-0617:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001299933-11-000095 |
| 2010-11-1516:39 ET | 10-Q | Quarterly reportPeriod 2010-09-30 | 0000950123-10-105751 |
| 2010-11-1214:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-10-004049 |
| 2010-10-0517:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-091452 |
| 2010-08-1617:10 ET | 10-Q | Quarterly reportPeriod 2010-06-30 | 0000950123-10-078110 |
| 2010-08-1616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-10-003092 |
| 2010-08-1317:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001299933-10-003084 |
| 2010-07-2218:55 ET | 8-K | 8.01 Other events | 0001299933-10-002760 |
| 2010-05-1715:13 ET | 10-Q | Quarterly reportPeriod 2010-03-31 | 0000950123-10-050308 |
| 2010-05-1415:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-10-001970 |
| 2010-04-2315:04 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001299933-10-001600 |
| 2010-04-0612:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001299933-10-001373 |
| 2010-03-2916:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001299933-10-001266 |
| 2010-03-2221:11 ET | DEF 14A | Proxy statementPeriod 2010-04-20 | 0000950123-10-026559 |
| 2010-03-1914:36 ET | 10-K | Annual reportPeriod 2009-12-31 | 0000950123-10-026333 |
| 2010-03-1111:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001299933-10-001025 |
| 2009-11-1217:15 ET | 10-Q | Quarterly reportPeriod 2009-09-30 | 0000950123-09-061846 |
| 2009-11-1017:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-09-004491 |
| 2009-09-0911:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001299933-09-003670 |
| 2009-08-3112:32 ET | 10-Q | Quarterly reportPeriod 2009-06-30 | 0000950123-09-039652 |
| 2009-08-2814:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-09-003550 |
| 2009-07-2915:52 ET | S-1/A | Registration statement, amended | 0000950123-09-026938 |
| 2009-07-1717:12 ET | S-1/A | Registration statement, amended | 0000950123-09-023228 |
| 2009-05-1216:31 ET | S-1/A | Registration statement, amended | 0000950144-09-004230 |
| 2009-04-1017:49 ET | S-1/A | Registration statement, amended | 0000950144-09-003082 |
| 2009-03-1817:01 ET | S-1/A | Registration statement, amended | 0000950144-09-002353 |
| 2009-02-1817:01 ET | S-1/A | Registration statement, amended | 0000950144-09-001408 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.